Back

Long-term outcomes of direct oral anticoagulants versus warfarin for chronic thromboembolic pulmonary hypertension: a reconstructed individual patient data meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Anticoagulation pharmacotherapy updates Anticoagulants ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Alvin Chng

Singapore (Singapore)

4 More presentations in this session

Presentation thumbnail
LOw-dose RAbeprazole therapy for reducing gastrointestinal events in patients with High Bleeding Risk (LORA-HBR): a prospective, multicenter, interventional study
Assistant Professor E. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Trends and outcomes of direct oral anticoagulant use in patients with cancer: a nationwide cohort study
Doctor A. Holt (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Effectiveness and safety of direct oral anticoagulants versus vitamin k antagonists in patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis
Mr K. Chagas (Itaperuna, BR)
Abstract Slides Video
Presentation thumbnail
The efficacy and safety of direct oral anticoagulants compared to warfarin for LV thrombus resolution
Doctor S. Azevedo (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Anticoagulation pharmacotherapy updates

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The efficacy and safety of direct oral anticoagulants compared to warfarin for LV thrombus resolution
thumbnail
Congress Presentation
Efficacy and safety of direct oral anticoagulants for treatment of left ventricular thrombus
thumbnail
Congress Session
Diagnosis and therapy of chronic thromboembolic pulmonary hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources